Three Psychedelic Companies Analysts Say Could Be Acquired Next
The Deal That Changed the Temperature Eli Lilly agreed in July to pay up to $3.8 billion for AtaiBeckley. That
Read MoreB2B resources and operational guidance for ketamine and psychedelic clinic owners.
The Deal That Changed the Temperature Eli Lilly agreed in July to pay up to $3.8 billion for AtaiBeckley. That
Read More
We just negotiated GPO-level medical supply pricing exclusively for Healing Health Alliance members. The proof: one HHA member ketamine practice
Read More
A Toronto trial paired ketamine with structured therapy for chronic nerve pain. It used three infusions over twelve weeks, not
Read More
The FDA finalized its first formal guidance for studying psychedelic drugs. The document sets the ground rules for research into
Read More
The WSJ reported that a SpaceX director gave $25 million to recapitalize the company behind MDMA-assisted therapy. That explains a
Read More